13F-HR filed by ACUTA CAPITAL PARTNERS, LLC
ACUTA CAPITAL PARTNERS, LLC filed this 13F-HR for the quarter ended 2017-03-31, filed 2017-05-15, with 67 holding rows worth $421,815,000.
- Accession
- 0001493152-17-005200
- Filer
- CIK 1582844
- Filed
- 2017-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2017
A holdings report, 67 entries on the cover page, a total value of $421,815,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $421,815,000 with VALUE read as thousands by filing date, 13F file number 028-16527. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 730,000 | $50,618,000 | thousands by filing date | put |
| iShares Russell 2000 ETF | 464287655 | SHS | 290,000 | $39,869,000 | thousands by filing date | put |
| VERACYTE INC COM | 92337F107 | Stock | 3,083,559 | $28,307,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 1,100,000 | $28,039,000 | thousands by filing date | |
| Lion Biotechnologies | 53619R102 | COM | 3,415,044 | $25,442,000 | thousands by filing date | |
| IRIDEX CORP | 462684101 | COM | 1,691,865 | $20,082,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 572,756 | $19,691,000 | thousands by filing date | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 550,000 | $15,400,000 | thousands by filing date | |
| EDGE THERAPEUTICS INC | 279870109 | COM | 1,351,516 | $12,312,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 450,000 | $11,948,000 | thousands by filing date | |
| WEBMD HEALTH CORP | 94770V102 | COM | 190,000 | $10,009,000 | thousands by filing date | call |
| NABRIVA THERAPEUTICS AG | 62957M104 | SPONSORED ADR | 677,710 | $8,133,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 920,310 | $7,731,000 | thousands by filing date | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 210,000 | $7,220,000 | thousands by filing date | call |
| VIVEVE MED INC | 92852W204 | COM NEW | 1,140,000 | $7,216,000 | thousands by filing date | |
| CAS MED SYS INC | 124769209 | COM | 4,422,500 | $6,413,000 | thousands by filing date | |
| CHEMBIO DIAGNOSTICS | 163572209 | COM | 1,202,144 | $6,371,000 | thousands by filing date | |
| OXFORD IMMUNOTEC GLOBAL PLC | G6855A103 | ORD SHS | 386,100 | $5,981,000 | thousands by filing date | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 200,000 | $5,964,000 | thousands by filing date | |
| TESARO INC | 881569107 | COM | 35,000 | $5,385,000 | thousands by filing date | |
| MARVELL TECHNOLOGY GROUP LTD | G5876H105 | ORD | 350,000 | $5,341,000 | thousands by filing date | |
| RA PHARMACEUTICALS INC | 74933V108 | COM | 247,956 | $5,279,000 | thousands by filing date | |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 149,690 | $5,272,000 | thousands by filing date | |
| ASSEMBLY BIOSCIENCES INC | 045396108 | COM | 200,000 | $5,098,000 | thousands by filing date | call |
| Johnson & Johnson | 478160104 | COM | 40,000 | $4,982,000 | thousands by filing date | put |
| ZOGENIX INC. | 98978L204 | Common Stock | 437,113 | $4,743,000 | thousands by filing date | |
| Viewra, Inc | 92672L107 | COM | 601,073 | $4,637,000 | thousands by filing date | |
| AVEXIS INC | 05366U100 | COM | 56,000 | $4,258,000 | thousands by filing date | |
| ANAPTYSBIO INC | 032724106 | COM | 165,690 | $4,138,000 | thousands by filing date | |
| NEURODERM LTD | M74231107 | ORD SHS | 150,000 | $3,983,000 | thousands by filing date | call |
| MEDICINES CO | 584688105 | COM | 70,000 | $3,423,000 | thousands by filing date | |
| EVOLENT HEALTH INC CL A | 30050B101 | Stock | 150,000 | $3,345,000 | thousands by filing date | |
| NANOSTRING TECHNOLOGIES INC | 63009R109 | COM | 164,932 | $3,277,000 | thousands by filing date | |
| IMMUNOMEDICS INC | 452907108 | COM | 503,000 | $3,254,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 400,000 | $2,936,000 | thousands by filing date | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 325,000 | $2,730,000 | thousands by filing date | call |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 40,361 | $2,570,000 | thousands by filing date | |
| CORBUS PHARMACEUTICALS HLDGS | 21833P103 | COM | 290,000 | $2,393,000 | thousands by filing date | put |
| MARVELL TECHNOLOGY GROUP LTD | G5876H105 | ORD | 147,500 | $2,251,000 | thousands by filing date | call |
| ESSA PHARMA INC | 29668H104 | COM | 605,300 | $1,876,000 | thousands by filing date | |
| NEKTAR THERAPEUTICS | 640268108 | COM | 76,600 | $1,798,000 | thousands by filing date | put |
| EVOLENT HEALTH INC CL A | 30050B101 | Stock | 80,000 | $1,784,000 | thousands by filing date | call |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 20,000 | $1,421,000 | thousands by filing date | put |
| PROGENICS PHARMACEUTICALS IN | 743187106 | COM | 150,000 | $1,416,000 | thousands by filing date | put |
| CLEARSIDE BIOMEDICAL INC | 185063104 | COM | 175,000 | $1,390,000 | thousands by filing date | |
| ALIMERA SCIENCES INC | 016259103 | COM | 974,318 | $1,364,000 | thousands by filing date | |
| SYNERON MEDICAL LTD | M87245102 | ORD | 122,400 | $1,291,000 | thousands by filing date | |
| VERACYTE INC COM | 92337F107 | Stock | 130,000 | $1,193,000 | thousands by filing date | call |
| ZOGENIX INC. | 98978L204 | Common Stock | 100,000 | $1,085,000 | thousands by filing date | put |
| ARRAY BIOPHARMA INC COM | 04269X105 | Stock | 120,500 | $1,077,000 | thousands by filing date | call |
| DBV TECHNOLOGIES S A | 23306J101 | ADR | 30,000 | $1,057,000 | thousands by filing date | call |
| VERSARTIS INC | 92529L102 | COM | 49,100 | $1,048,000 | thousands by filing date | put |
| ADVISORY BOARD CO/THE | 00762W107 | Domestic Common | 21,300 | $997,000 | thousands by filing date | |
| XBIOTECH INC | 98400H102 | COM | 60,000 | $989,000 | thousands by filing date | call |
| PROGENICS PHARMACEUTICALS IN | 743187106 | COM | 100,000 | $944,000 | thousands by filing date | |
| ROCKWELL MED INC | 774374102 | COM | 140,000 | $876,000 | thousands by filing date | put |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 49,051 | $837,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 70,000 | $774,000 | thousands by filing date | put |
| AEHR TEST SYSTEMS | 00760J108 | COMMON STOCK | 122,000 | $587,000 | thousands by filing date | |
| INVITAE CORP | 46185L103 | COM | 50,000 | $553,000 | thousands by filing date | call |
| OMEROS CORP | 682143102 | COM | 30,000 | $454,000 | thousands by filing date | call |
| XBIOTECH INC | 98400H102 | COM | 20,000 | $330,000 | thousands by filing date | put |
| Lion Biotechnologies | 53619R102 | COM | 40,000 | $298,000 | thousands by filing date | call |
| QUOTIENT LTD | G73268107 | SHS | 18,900 | $132,000 | thousands by filing date | |
| ONCOBIOLOGICS INC | 68235M105 | COM | 29,082 | $78,000 | thousands by filing date | |
| ONCOBIOLOG-CW17A | 68235M113 | EQUITY WRT | 96,833 | $77,000 | thousands by filing date | |
| ONCOBIOLOGICS INC | 68235M121 | *W EXP 05/18/201 | 96,833 | $48,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001493152-17-005200 | this filing | 2017-05-15 | acceptance time not in the bulk data set |